Curis
CRIS
#11081
Rank
HK$5.29 M
Marketcap
HK$2.72
Share price
-17.89%
Change (1 day)
-78.76%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -HK$53.84 Million

According to Curis's latest financial reports the company's current earnings are HK$7.06 Million. In 2025 the company made an earning of -HK$42.33 Million, an increase over its 2024 earnings that were of -HK$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$53.84 Million27.2%
2025 -HK$42.33 Million-87.38%
2024 -HK$0.34 Billion-5.77%
2023 -HK$0.36 Billion-13.1%
2022 -HK$0.41 Billion27.52%
2021 -HK$0.33 Billion65.09%
2020 -HK$0.2 Billion-9.1%
2019 -HK$0.22 Billion-4.73%
2018 -HK$0.23 Billion-41.95%
2017 -HK$0.39 Billion-14.37%
2016 -HK$0.46 Billion3.55%
2015 -HK$0.44 Billion271.52%
2014 -HK$0.12 Billion76.64%
2013 -HK$66.51 Million
2011 -HK$56.49 Million27.76%
2010 -HK$44.22 Million-43.87%
2009 -HK$78.78 Million-23.44%
2008 -HK$0.11 Billion56.66%
2007 -HK$65.68 Million-16.71%
2006 -HK$78.86 Million-36.92%
2005 -HK$0.13 Billion156.25%
2004 -HK$48.78 Million-37.24%
2003 -HK$77.73 Million-93.34%
2002 -HK$1.17 Billion86.79%
2001 -HK$0.63 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$83.05 B-156,794.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$75.25 B-142,088.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$0.49 Billion 815.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$7.86 B-14,942.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2.43 Billion 4,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$0.18 Billion 228.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$0.46 B-974.39%๐Ÿ‡บ๐Ÿ‡ธ USA